Siltuximab(CNTO-328) is a monoclonal antibody with anti-tumor activity targeting IL-6 for the study of giant lymph node hyperplasia (MCD) and COVID-19.
CAS Number:
[541502-14-1]
Target:
IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted